|
||
© The Rockefeller University Press,
0021-9525/1997//205 $5.00
The Journal of Cell Biology, Volume 139, Number 1,
, 1997 205-217
Article |
Bax Deletion Further Orders the Cell Death Pathway in Cerebellar Granule Cells and Suggests a Caspase-independent Pathway to Cell Death


Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110
Dissociated cerebellar granule cells maintained in medium containing 25 mM potassium undergo an apoptotic death when switched to medium with 5 mM potassium. Granule cells from mice in which Bax, a proapoptotic Bcl-2 family member, had been deleted, did not undergo apoptosis in 5 mM potassium, yet did undergo an excitotoxic cell death in response to stimulation with 30 or 100 µM NMDA. Within 2 h after switching to 5 mM K+, both wild-type and Bax-deficient granule cells decreased glucose uptake to <20% of control. Protein synthesis also decreased rapidly in both wild-type and Bax-deficient granule cells to 50% of control within 12 h after switching to 5 mM potassium. Both wild-type and Bax –/– neurons increased mRNA levels of c-jun, and caspase 3 (CPP32) and increased phosphorylation of the transactivation domain of c-Jun after K+ deprivation. Wild-type granule cells in 5 mM K+ increased cleavage of DEVD–aminomethylcoumarin (DEVD-AMC), a fluorogenic substrate for caspases 2, 3, and 7; in contrast, Bax-deficient granule cells did not cleave DEVD-AMC. These results place BAX downstream of metabolic changes, changes in mRNA levels, and increased phosphorylation of c-Jun, yet upstream of the activation of caspases and indicate that BAX is required for apoptotic, but not excitotoxic, cell death. In wild-type cells, Boc-Asp-FMK and ZVAD-FMK, general inhibitors of caspases, blocked cleavage of DEVD-AMC and blocked the increase in TdT-mediated dUTP nick end labeling (TUNEL) positivity. However, these inhibitors had only a marginal effect on preventing cell death, suggesting a caspase-independent death pathway downstream of BAX in cerebellar granule cells.
Abbreviations used in this paper: BAF, Boc-aspartyl(OMe)-fluoromethylketone; NMDA, N-methyl-D-aspartic acid; PI-3-K, phosphatidylinositol-3 kinase; PCD, programmed cell death; TUNEL, TdT-mediated dUTP nick end labeling.
EXTENSIVE cell death is an important part of the development and ongoing maintenance of tissues in multicellular organisms (Glucksman, 1951; Clarke and Clarke, 1996). The demise of many cells is modulated by members of the BCL-2 family of proteins (Korsmeyer, 1996; White, 1996). BCL-2 was first recognized as a modulator of cell death in studies of follicular B cell lymphoma in which overexpression of BCL-2 promotes transformation by rendering cells more resistant to apoptosis. The antiapoptotic activity of BCL-2 has been borne out in numerous cell types in response to a variety of stimuli (for review see Korsmeyer, 1996; White, 1996).
Several homologues of BCL-2 have been isolated, including some members of this family that are antiapoptotic, like BCL-2, and others that are proapoptotic (for review see Korsmeyer, 1996; White, 1996). BCL-2 family members that inhibit apoptosis include CED-9, MCL-1, A1, and E1B-19K. Family members that promote apoptosis include BAX, BAK, and BAD. BCL-X, another BCL-2 homologue, has both an antiapoptotic, long-splice variant, BCL-XL, and a proapoptotic, short-splice variant, BCL-XS. While the essential biochemical function of BCL-2 family members remains under investigation, their activity is regulated, in part, by dimerization among the various family members (Korsmeyer, 1996; Oltvai et al., 1993). In this rheostat model, the ratio of proapoptotic versus antiapoptotic molecules determines the fate of a cell. Dimerization among family members is mediated by three highly conserved domains, BH1, BH2, and BH3. BH1 and BH2 appear critical for antiapoptotic members (BCL-2 and BCL-XL) to heterodimerize with the proapoptotic BCL-2 family member, BAX (Yin et al., 1994), while the BH3 domain of BAX is essential for its heterodimerization and activity (Chittenden et al., 1995) .
Studies of mice deficient in BCL-X or BAX have highlighted these two family members as particularly important for the nervous system. Apoptosis in developing sensory and central nervous system neurons is greatly increased in mice deficient in Bcl-X (Motoyama et al., 1995). Dissociated sympathetic neurons from Bax-deficient animals are remarkably resistant to trophic factor deprivation–induced death, and motor neurons from the facial nucleus do not degenerate in response to axotomy (Deckwerth et al., 1996). In contrast, isolated thymocytes from Bax-deficient mice are not resistant to apoptosis (Knudson et al., 1995). In this study, we determined whether BAX was critical for cerebellar granule cell apoptosis.
Dissociated cerebellar granule cells from early postnatal rats can be maintained in serum-containing medium by elevating extracellular potassium levels (25 mM) (Gallo et al., 1987), or by adding low concentrations of N-methyl-D-aspartic acid (NMDA)1 to the culture medium (Balazs et al., 1988). Both low concentrations of NMDA and depolarization are presumed to mimic endogenous excitatory activity (Burgoyne et al., 1993); the survival promotion is mediated by increases in intracellular calcium (Gallo et al., 1987). Overstimulation of glutamate receptors on granule cells leads to an excitotoxic death (Schramm et al., 1990; Dessi et al., 1993; Lafon-Cazal et al., 1993). Dissociated cerebellar granule cells develop characteristics of mature cerebellar granule cells in vivo including an extensive neuritic network, expression of excitatory amino acid receptors, and production and release of L-glutamate (Burgoyne et al., 1993). Removal of both potassium and serum from dissociated cerebellar granule cells triggers a cell death that is morphologically apoptotic, accompanied by DNA fragmentation, and dependent on macromolecular synthesis (D'Mello et al., 1993; Nardi et al., 1997). This apoptotic cell death presumably mimics the naturally occurring death of 20–30% of granule cells (Caddy and Biscoe, 1979), which is important for matching the number of granule cells with Purkinje cells, that occur during the third through fifth postnatal weeks (Wetts and Herrup, 1983; Williams and Herrup, 1988).
In the current study, we demonstrate that BAX is required for programmed cell death (PCD), but not excitotoxic cell death, of cerebellar granule cells. We used this homogeneous population of BAX-dependent neurons to assess when BAX was acting in the program that commits a cell to die. We found that while Bax-deficient granule cells did not die, they did progress through several early changes associated with neuronal PCD (Deckwerth and Johnson, 1993; Estus et al., 1994; Freeman et al., 1994; Miller and Johnson, 1996) including decreases in protein synthesis and glucose uptake, and an increase in the mRNA level of the AP-1 transcription factor c-jun. In contrast to these events that do occur in both Bax +/+ and Bax –/– cells, we found that Bax –/– lysates did not cleave Ac-DEVD-aminomethylcoumarin (DEVD-AMC), a fluorogenic substrate for caspases 2, 3, and 7 that was cleaved by lysates from wild-type cells undergoing apoptosis. These results identify a central nervous system cell type that requires BAX to undergo PCD and clearly place BAX downstream of changes in glucose uptake, protein synthesis, and certain mRNA levels and upstream of the activation of a DEVD-selective caspase. We further investigated the role of the caspases in PCD of granule cells by using peptide inhibitors of caspases. Although these compounds blocked cleavage of DEVD-AMC completely and blocked the increase in TdT-mediated dUTP nick end labeling (TUNEL)–positivity, they only had a marginal effect on cell survival, suggesting the presence of caspase-independent cell death effectors downstream of BAX.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture Media
All culture media were based on Basal Medium Eagle (Life Technologies, Grand Island, NY) containing 100 U/ml penicillin and 100 µg/ml streptomycin. The following additions were made: K5+S medium, 10% dialyzed FBS 10,000 mol wt cutoff (Sigma Chemical Co., St. Louis MO); K25+S medium, 10% dialyzed FBS, 20 mM KCl; K25–S medium, 20 mM KCl; K5–S medium, no additions. Dialyzed serum was used because adding fresh medium containing nondialyzed serum to cerebellar granule cells is toxic. This sensitivity to nondialyzed serum develops after several days in culture because of the glutamate in the serum (Schramm et al., 1990).
Neuronal Culture
This cell culture protocol is a modification of previous protocols (Levi et al., 1984) and is extensively detailed in Miller and Johnson (1996). The only difference was that cerebella from Bax +/+, Bax +/–, Bax –/– were treated as separate, parallel dissections. In brief, cerebella were dissected from postnatal day seven (P7) mice, sliced into 1-mm pieces, and incubated at 37°C for 15 min in 0.30 mg/ml trypsin (Worthington Biochemical Corp., Freehold, NJ). The tissue was then triturated in K25+S medium with 0.5 mg/ml trypsin inhibitor (Sigma Chemical Co.) by using a flame-polished Pasteur pipette. The resulting cell suspension was spun at 500 g for 6 min. The pellet was gently triturated in fresh K25+S medium and filtered through a nitex filter (size 3-20/14; Tetko Inc., Elmsford, NY). Trypan blue exclusion was used to determine the number of the living neurons before plating: 2–2.5 x 105 cells/cm2 in either four-well (Nunc, Naperville, IL) or 35-mm dishes (Corning Inc., Corning, NY). Before plating, dishes were coated with 0.1 mg/ml poly-L-lysine (P2636; Sigma Chemical Co.). The granule cells were kept at 35°C in a humidified incubator with 5% CO2/95% air for 7 d. Fresh K25+S medium was added after 4 d in vitro. To reduce the number of nonneuronal cells, aphidicolin (3.3 µg/ ml, Sigma Chemical Co.) was added to the medium 24–36 h after initial plating. The culture conditions do not support the survival of other neuronal cell types (Thangnipon et al., 1983; Kingsbury et al., 1985); the nonneuronal contamination was 1–2% (Miller and Johnson, 1996).
Treatment of Cultures
For studies of potassium deprivation, phosphatidylinositol-3 kinase (PI-3-K) inhibition, or inhibition of caspases, at 7 d in vitro, culture medium was replaced with either K5–S or K5+S medium after washing cells once with the respective medium. Control cultures were treated identically with K25+S medium. Special care was taken to assure that all media had been preincubated at 35°C, 5% CO2/95% air for 18–24 h. 30 µM LY 294002 (Biomol Research Laboratories, Inc., Plymouth, PA) was added to K25+S medium to inhibit PI-3-K. Boc-aspartyl(OMe)-fluoromethylketone (BAF) and Z-VAD-fluoromethylketone were obtained from Enzyme Systems Products (Dublin, CA).
For NMDA stimulation, cells were treated at 10 d in vitro as described in Lafon-Cazal et al. (1993). Culture medium was removed and placed at 35°C, 5% CO2/95% air. Cultures were washed twice for 15 min at 35°C in Mg2+-free Locke's solution (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO3, 2.7 mM CaCl2, 5.6 mM D-glucose, 5 mM Hepes, pH 7.4) and then incubated at 35°C for 30 min in Mg2+-free Locke's solution with 3 µM glycine (Sigma Chemical Co.) and 10, 30, or 100 µM NMDA (Sigma Chemical Co.), or 100 µM NMDA + 150 nM MK-801 (Research Biochemicals International, Natick, MA). Cells were washed twice for 15 min with Mg2+-free Locke's solution at 35°C. The original culture medium was replaced and the cells were incubated at 35°C, 5% CO2/95% air for 24 h after which cell viability was assessed.
Determination of Cell Viability
Cell viability was quantified from photomicrographs of representative fields of cells labeled with calcein AM (Molecular Probes Inc., Eugene, OR). Calcein AM is an acetoxymethyl ester fluorescein derivative, which is cleaved and trapped inside viable cells that have nonspecific esterase activity (Bozyczko et al., 1993). The photomicrographs were both taken and scored by an observer naive to the experimental condition and to the genotype of the animal from which the culture was derived. Six photomicrographs at 200 magnification were taken for each condition and the number of calcein AM–positive cells was counted. This method of quantifying cell viability is detailed and validated in Miller and Johnson (1996).
Metabolic Parameters
Experiments were performed in four-well dishes (Nunc) with
400,000 cells per well. After 7 d in vitro, culture medium was replaced with K5+S or K25+S medium (as described above). Detailed description of the following methods may be found in Deckwerth and Johnson (1993) and Miller and Johnson (1996).
Rate of Protein Synthesis.
Neuronal cultures were labeled for 1 h at 35°C with 10 µCi/ml L-[4,5-3H]leucine (159 Ci/mmol; Amersham Life Science, Inc., Arlington Heights, IL) in K25+S or K5+S medium containing 10 µM unlabeled L-leucine. Cultures were lysed, precipitated with 10% trichloroacetic acid (TCA), filtered, and counted in a liquid scintillation counter (Beckman Instrs., Fullerton, CA).
Rate of 2-deoxyglucose Uptake.
Neuronal cultures were labeled for 30 min at 35°C with 2.5 µCi/ml [1,2-3H]2-deoxy-D-glucose (30 Ci/mmol; ICN Biomedicals, Inc., Irvine,CA) in K25+S or K5+S medium containing 500 µM D-glucose. Cultures were washed three times, lysed, and added directly to liquid scintillation fluid and counted. Assays were linear with respect to time during the indicated measuring period (data not shown).
RT-PCR
Semiquantitative reverse transcription-PCR (RT-PCR) assays are based on those used for sympathetic neurons described in Freeman et al. (1994) and Estus et al. (1994), and extensively detailed by Estus (1997). Briefly, granule cells were switched to K5+S for the indicated times. Polyadenylated (poly-A) RNA was isolated from 400,000 cerebellar granule cells by using an oligo-dT-cellulose mRNA purification kit as directed by the manufacturer (QuickPrep Micro Kit; Pharmacia LKB Biotechnology Inc., Piscataway, NJ). Half of the poly-A RNA was converted to cDNA by reverse transcription (RT) with Moloney murine leukemia virus reverse transcriptase with random hexamers (16 µM) as primers. cDNA from
4,000 cells was used in a 50 µl PCR reaction. After amplification, the PCR products were separated by electrophoresis on 10% polyacrylamide gels, visualized by autoradiography of the dried gels, and quantified with a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA). Preliminary experiments with cerebellar granule cell cultures validated that the RT-PCR technique was linear with respect to the amount of input RNA used for RT and with respect to the amount of cDNA used for PCR within the ranges used in these experiments. No product was amplified when purified RNA was used as input for a PCR reaction. Results were repeated in at least two independent RNA preparations. The sequences of the PCR products were confirmed (Estus et al., 1994; Freeman et al., 1994; data not shown). Primer sequences for cyclophilin and cyclin D1 are reported in Freeman et al. (1994). Sequences for c-fos and c-jun are reported in Miller and Johnson (1996). Bax primer sequences are detailed in Greenlund et al. (1995). Primer sequences for CPP32 (EMBL/GenBank/DDBJ accession number D86352), ICH-1 (U13022), and GFAP (X02801) are as follows (5' to 3'): CPP32 (–569) AGA GTA AGC ATA CAG GAA GTC GGC; CPP32(+351) GAT TCT AAG TCA TGG AGA TGA AGG; ICH1 (fwd) GGT TGA GAT GGC AAA CTG CT; ICH1 (rev) CCA GCA TCA CTC CC TCA CA; GFAP (+2092) CAA TGG AGT TGG AAG TTG TAG GC; and GFAP (–2245) GAT AGA CCT TCA CAA CTG AGA CG.
DEVD-AMC Cleavage Assay
DEVD-AMC cleavage was measured essentially as described (Armstrong et al., 1997). After 0, 4, 8, 12, 24, or 48 h in K5+S medium, 400,000 granule cells were washed once with PBS and lysed in 100 µl of buffer A (10 mM Hepes, pH 7.4, 42 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.5% CHAPS, 1 mM PMSF, 1 µg/ml leupeptin). In a 96-well plate, 25 µl of lysate was combined with 75 µl of buffer B (25 mM Hepes, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, 3 mM DTT, pH 7.5) containing 30 µM Ac-DEVD-AMC (Biomol Research Laboratories, Plymouth, PA) and incubated for 20 min at room temperature in the dark. Fluorescence was measured at excitation 360 nm and emission 460 nm in a fluorescent plate reader (Titertek Fluoroskan II; Flow Laboratories, Inc., McLean, VA). 20 min and 25 µl were both in the linear range of the assay with respect to time and amount of lysate added.
Although cultures were extensively washed before lysing cells, we were concerned that residual BAF or ZVAD from the culture medium might account for the block in DEVD-AMC cleavage in our enzyme assay. To test this possibility, we combined 8-h K+ deprivation lysates from BAF- or ZVAD-treated cultures with 8-h K+ deprivation lysates from untreated cultures and determined DEVD-AMC cleavage. We found that the 8-h lysates from the BAF- or ZVAD-treated cultures did not themselves contain any ability to inhibit the DEVD-AMC cleavage activity in our assay, demonstrating that the BAF and ZVAD in the culture medium had been adequately washed out before lysis (data not shown).
Transfections of Cerebellar Granule Cells
All constructs were under the cytomegalovirus (CMV) promoter. pGreen Lantern-1 (green fluorescent protein) was obtained from GIBCO BRL (Gaithersburg, MD). The BCL-2 construct is detailed in Greenlund et al. (1995a). The p35 construct was a generous gift from Dr. Lois K. Miller. pBluescript II was used as control DNA (Short et al., 1988). Granule cells were transfected essentially as described in Xia et al. (1995). In brief, after 5 d in vitro, cultures were switched to K25–S medium for 1 h after which DNA/CaCl2 precipitates were prepared as follows: An equal volume of solution containing 0.25 M CaCl2, 67 µg/ml pGreen Lantern-1 DNA, and 67 µg/ml of either Bax, BCL-2, or p35 DNA was added to 2x Hepes-buffered saline (274 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4-7H20, 15 mM dextrose, 42 mM Hepes-free acid, pH 7.07) and incubated in the dark at room temperature for 25 min. 30 µl of the CaCl2 precipitate (1 µg of DNA) was added dropwise to each well of a Nunc four-well plate containing
400,000 granule cells and incubated for 1 h at 37°C. Cells were washed twice with K25–S medium and returned to K25+S medium for 2 d after which the number of transfected cells was assessed by counting the number of pGreen Lantern-1 (fluorescent) cells (
200) in a defined area for two separate wells of a Nunc four-well dish. Transfection efficiency was typically 0.2%. Cells were then switched to K5+S or K25+S medium, and the number of fluorescent cells was again assessed for the same defined area after 24 and 48 h and compared to the original number for a particular well. All cultures were counted by a naive observer. pGreen Lantern-1 positivity correlated well with a healthy, viable cell as assessed by phase-contrast microscopy, nuclear morphology, and exclusion of trypan blue. Preliminary experiments using both pGreen Lantern-1 and LacZ as markers of transfection demonstrated that all cells that were pGreen Lantern-1–positive were also LacZ-positive and vice versa. In addition, from the earliest time that pGreen Lantern-1 could reliably be detected (24 h), expression of the constructs was not toxic to the cells up to 9 d after transfection.
Phospho-Jun Staining
Neuronal cultures were washed once with PBS, pH 7.4, before a 30-min fixation with 4% paraformaldehyde in PBS at 4°C. Neuronal cultures were washed three times with TBS (100 mM Tris, 0.9% NaCl, pH 7.6), blocked for 30 min in TBS containing 5% goat serum (Sigma Chemical Co.) and 0.3% Triton X-100 at room temperature, and incubated overnight at 4°C with anti–phospho–c-jun antibody (Ser 63; New England Biolabs Inc., Beverly, MA) diluted 1:200 in TBS containing 1% goat serum and 0.3% Triton X-100. Cultures were washed three times with TBS then incubated overnight at 4°C in a 1:400 dilution of 1.5 mg/ml Cy3-donkey anti–rabbit antibody (Jackson Immunoresearch Laboratories, Inc., Westgrove, PA) in the same buffer as the primary antibody. Cultures were washed twice with TBS, stained with 1 µg/ml bisbenzimide (Hoechst 33258; Molecular Probes Inc., Eugene, OR) for 20 min to visualize nuclei, then washed two additional times with TBS. The phospho-jun antibody does not react with the nonphosphorylated form of c-Jun and does not appreciably cross-react with the phosphorylated form of JunD or JunB (New England Biolabs Inc.).
TUNEL Staining
At 7 d in vitro, culture medium from cerebellar granule cells was replaced with either K5+S, K5+S plus 100 µM BAF, or fresh K25+S after washing the cells once with the appropriate medium. At 24 h after this treatment, cells were examined for DNA fragmentation using the In Situ Cell Death Detection Kit (Fluorescein; Boehringer Mannheim Biochemicals, Indianapolis, IN) according to the manufacturer's instructions. In brief, cells were fixed for 30 min in 4% paraformaldehyde/PBS at room temperature, washed once with PBS, and permeabilized in 0.1% Triton X-100, 0.1% sodium citrate for 20 min at 4°C. After two more washes with PBS, the cells were incubated with 50 µl of the TUNEL reagent for 1 h at 37°C in the dark. Cells were then washed twice with PBS, stained with 1 µg/ml Hoechst 33258 (Molecular Probes Inc.), and washed twice more with PBS. The percentage of TUNEL-positive cells was calculated as the number of TUNEL-positive cells divided by the number of Hoechst-stained cells. For each condition, a naive observer counted two to five fields, each containing over 200 bisbenzimide-stained neurons. Results represent mean ± range for two independent experiments.
| RESULTS |
|---|
|
|
|---|
|
|
We have previously shown that PI-3-K activity is increased by K+ depolarization (Miller et al., 1997). This increase appears critical to the survival of depolarized neurons as shown by the ability of two inhibitors of PI-3-K to produce death indistinguishable from that caused by removal of high K+ (Miller et al., 1997). Because BCL-2 family members have been recently implicated in signaling pathways (Gajewski and Thompson, 1996; Wang et al., 1996; Zha et al., 1996), we directly tested the ability of Bax –/– cells to survive in the absence of PI-3-K activity. Neurons maintained for 7 d in vitro were switched to K25+S with 30 µM LY 294002, an inhibitor of PI-3-K activity. Viability was assessed after 48 h by calcein AM staining (Fig. 3). Similar to previous results (Miller et al., 1997), LY 294002 blocked the survival-promoting activity of K+ in Bax +/+ cells. Results from cultures of animals heterozygous for Bax were similar to those from wild type. In contrast, neurons from Bax –/– cultures survived in the presence of LY 294002, implying that Bax deficiency blocked apoptosis downstream of PI-3-K.
|
| BAX –/– NEURONS ARE NOT PROTECTED FROM EXCITOTOXIC DEATH |
|---|
|
|
|---|
|
|
Whether the increase in c-jun mRNA and presumably the action of c-jun is downstream or upstream of BAX is unknown. To address this issue and examine other message levels, cultures from Bax +/+ and Bax –/– animals were switched to K5+S for 1, 3, 6, 9, 12, 18, 24, 48, or 72 h and mRNA was isolated, reverse transcribed, and selectively amplified by PCR. mRNA levels of cyclophilin declined rapidly in wild-type granule cells (Fig. 6, A and B); actin and neuron-specific enolase were similar to cyclophilin (data not shown). mRNA levels of these same messages in Bax –/– cultures declined far less than in wild-type cultures reflecting the lack of death of Bax –/– cells (Fig. 6, A and C). Similar to results seen in rat cerebellar granule cells (Miller and Johnson, 1996), mRNA levels for c-jun increased approximately fourfold in K+-deprived wild-type granule cells (Fig. 6 B). c-jun mRNA also increased in K+-deprived, Bax-deficient granule cells (Fig. 6 C), demonstrating that increases in c-jun were upstream of Bax.
|
mRNA levels of caspase 3 (CPP32) increased in both wild-type and Bax-deficient cultures deprived of K+ (Fig. 6). Caspase 3 has been clearly implicated in several cell death paradigms (for review see Henkart, 1996) and in developmental neuronal cell death (Kuida et al., 1996), although whether increases in mRNA levels of caspases have any significance for cell death is unclear. The mRNA level of at least one other caspase, caspase 2 (Ich-1), was not increased after K+ deprivation (data not shown).
c-Jun Is Phosphorylated on Ser 63 in Both Bax +/+ and Bax –/– Cultures
In addition to increases in mRNA levels, another indication of an increase in c-Jun activity is the phosphorylation of c-Jun on serines 63 and 73 of the transactivation domain (Binetruy et al., 1991; Smeal et al., 1991, 1992). Therefore, we determined the phosphorylation status of the c-Jun transactivation domain during PCD by immunostaining with an antibody that specifically recognizes the serine 63– phosphorylated form of c-Jun (Fig. 7). Cells maintained in K25+S medium (Fig. 7, a and e) had almost no staining. After 6 h of K+ deprivation, wild-type granule cells showed significant phosphorylation of c-Jun on serine 63 (Fig. 7 c). Similar to the parallel increases in c-jun mRNA levels in Bax +/+ and Bax –/– cultures, phospho-Jun staining also increased in Bax –/– granule cells deprived of K+ for 6 h (Fig. 7 g). Staining was not increased in the few nonneuronal cells in these cultures (data not shown). In nuclei counterstained with bisbenzimide (Fig. 7, b, d, f, and h), some K+-deprived, wild-type cells showed nuclear margination and chromatin condensation at 6 h (Fig. 7 d). The increase in c-Jun phosphorylation and c-jun mRNA in both wild-type and Bax –/– cultures indicates that BAX functions downstream of the increase in c-Jun activity that is associated with PCD.
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
|
BAX Is Not Required for Changes in Metabolic Parameters or mRNA Levels
The early, dramatic fall in metabolic parameters that we saw in Bax –/– cultures is part of the cell death program in cerebellar granule cells (Miller and Johnson, 1996; Nardi et al., 1997), sympathetic neurons (Deckwerth and Johnson, 1993), and thymocytes (Makman et al., 1966; Munck, 1968; Cidlowski, 1982). Thus, we have hypothesized that these events may represent an early trigger for PCD. The early decreases in glucose uptake and protein synthesis rate were not affected by the Bax genotype. This suggests that the actions of BAX are not related to early signal transduction pathways mediating neuronal survival by trophic signals. This conclusion is further supported by the inability of PI-3-K inhibitors to induce cell death in Bax –/– cells. It is also consistent with previous observations that overexpression of BCL-2, while greatly retarding sympathetic neuronal death after NGF deprivation, has no effect on the decrease in protein synthesis that presages that death (Greenlund et al., 1995b).
The deletion of BAX also failed to block changes in mRNA levels, another step in the cell death program; c-jun mRNA increased in both Bax +/+ and Bax –/– cultures. Several reports have suggested that c-Jun may be important for cell death. Microinjection of neutralizing antibodies to c-Jun or a dominant negative c-jun construct delays the death of NGF-deprived sympathetic neurons (Estus et al., 1994; Ham et al., 1995). Dominant negative c-jun constructs also block cell death in human monocytic leukemia cells (U937) treated with ceramide (Verheij et al., 1996). An increase in c-Jun is evidently part of cell death in vivo. c-Jun increases in granule cells undergoing PCD in the weaver mouse (Gillardon et al., 1995) and in irradiated animals (Ferrer et al., 1996). c-Jun amino-terminal kinase (JNK) (Hibi et al., 1993) may be the kinase responsible for the increased phosphorylation on serine 63 of c-Jun in both Bax +/+ and Bax –/– cells (Fig. 7). Several reports have implicated this pathway during cell death (Xia et al., 1995; Chen et al., 1996; Latinis and Koretzky, 1996; Park et al., 1996; Verheij et al., 1996; Wilson et al., 1996). The increase in c-Jun both in vitro and in vivo, the fact that blocking c-Jun delays cell death, and increases in c-Jun phosphorylation during PCD imply that an increase in c-Jun is an important early occurrence during PCD. In PC12 cells, overexpression of Bcl-2 is able to block the increase in JNK activity associated with PCD, suggesting that the BCL-2 family functions upstream of c-Jun (Park et al., 1996). Our loss of function study with BAX is in apparent disagreement with these data. In cerebellar granule cells, the increase in c-jun message level and the phosphorylation of c-Jun are clearly upstream of BAX (Figs. 6 and 7).
Caspase Activity
We examined the role of caspases in PCD in granule cells by determining changes in mRNA levels of caspase 3 (CPP32) and increases in the activity of DEVD selective caspases. K+ deprivation increased caspase 3 mRNA levels in Bax +/+ and Bax –/– cultures. An increase in the message level of caspase 3 also occurs in response to focal ischemic injury (Asahi et al., 1997). Similarly, loss of expression of caspase 1 (ICE) in mammary epithelial cells correlates with the suppression of apoptosis by extracellular matrix (Boudreau et al., 1995). However, whether these changes in mRNA levels are important for cell death or lead to increases in activity of caspases is unclear.
We directly measured the activity of caspases 2, 3, and 7 and found that wild-type granule cells increased DEVD-specific substrate cleavage after K+deprivation (Fig. 8). Other groups have similarly reported that DEVD-AMC is cleaved in granule cells after K+/serum deprivation (Armstrong et al., 1996; Nath et al., 1996). The increase in the activity of DEVD-selective caspases is an event that clearly occurs downstream of BAX in cerebellar granule cells (Fig. 8) since Bax –/– cultures showed no increase in DEVD-AMC cleavage after K+ deprivation. Similarly, overexpression of BCL-2 prevents activation of caspases in Jurkat cells (Armstrong et al., 1996; Chinnaiyan et al., 1996), in GT1-7 neural cells (Srinivasan et al., 1996), and in PC12 cells (Stefanis et al., 1996).
Caspase Inhibitors Do Not Block Granule Cell Death
We were surprised by the failure of the baculoviral protein p35 or pharmacological caspase inhibitors to block PCD in cerebellar granule cells. Although inhibiting caspases does delay cell death in granule cells up to 24 h (Nath et al., 1996; Schulz et al., 1996; Armstrong et al., 1997), our data indicate that these compounds did not offer any substantial long-term protection (Fig. 9). This contrasts with sympathetic neurons in which PCD is prevented completely for at least 7 d by BAF (Deshmukh et al., 1996). These results suggest that granule cells have, in addition to a caspase-dependent pathway, a caspase-independent pathway downstream of BAX that insures cell death.
Our suggestion that at least two pathways exist downstream of BAX presumes that all potential caspases were effectively blocked in these studies. We demonstrated that DEVD-AMC cleavage was blocked completely in these cells, showing that the compounds used were able to penetrate the cells and function as caspase inhibitors. BAF, ZVAD-FMK (Armstrong et al., 1996; Cain et al., 1996; Deshmukh et al., 1996), and p35 (Bump et al., 1995; Xue and Horvitz, 1995) are nonspecific inhibitors with reasonable IC50s that block the activity of a wide spectrum of caspases. We cannot formally exclude the possibility that an atypical caspase might have been activated in granule cells in the presence of these inhibitors. Similarly, cell death in the presence of p35 might be accounted for by inadequate levels of protein expression.
The fact that cell death in the presence of caspase inhibitors was TUNEL-negative, while K+ deprivation induced was TUNEL-positive, provided further evidence for the ability of caspase inhibitors to function inside of cells. The nuclear morphology of dying BAF- and ZVAD-treated granule cells may also be an indication that these compounds blocked caspases. While BAF- and ZVAD-treated nuclei did condense, we found no evidence for margination or clumping of the chromatin typically observed in apoptotic cells, though these changes were apparent in untreated, K+-deprived cells (Miller, T.M., personal observation). The ability of caspase inhibitors to block lamin proteolysis (Lazebnik et al., 1995) may account for the lack of margination and chromatin clumping (Rao et al., 1996). In addition to demonstrating that these caspase inhibitors did function within cells, these data raise the possibility that the modestly slower, caspase-independent cell death in granule cells differs fundamentally from the cell death that normally occurs after K+ deprivation when caspases are unimpeded. Further studies of this caspase-independent, TUNEL-negative cell death may elucidate important differences between these two cell death pathways.
Evidence in a different system using an alternative approach has also recently suggested a BAX-dependent, protease-independent mechanism of cell death. BAX overexpression in Jurkat cells leads to an apoptotic-like death that is not blocked by caspase inhibitors, calpain inhibitors, serine protease inhibitors, granzyme B inhibitors, or proteasome inhibitors (Xiang et al., 1996). In these overexpressing Jurkat cells, as observed here, caspase inhibitors do block DNA fragmentation and cleavage of substrates for caspases; however, these cells still die. In Jurkat cells, a fall in mitochondrial membrane potential and an increase in ROS occurs (Xiang et al., 1996). These mitochondrial changes and the membrane localization of BAX suggest that a mitochondria-dependent cell death predominates in BAX gain of function experiments (Xiang et al., 1996). Data here in the experimental setting of BAX loss-of-function provide support for the possibility that a non–caspase-dependent, TUNEL-negative, cell death pathway resides downstream of BAX.
In summary (Fig. 12), K+ and IGF-I block the activation of the cell death program in granule cells. When these agents are removed and the program is activated, MAP kinase activity, PI-3-K activity, metabolic parameters, and most mRNA levels decrease, while some mRNA levels, e.g., c-jun, increase. Our data from the Bax –/– mice place BAX downstream of these changes. The PCD events subsequent to BAX include increased caspase activity and some other change(s) that promote DNA fragmentation, chromatin condensation, and cell death.
Bax –/– granule cell cultures offer an informative perspective on cell death because these cells clearly progress through part of the apoptotic program and then are completely halted. These cultures should be a valuable tool for further ordering the molecular pathways leading to cell death, for defining the role of the BCL-2 family in apoptosis, and, potentially, for identifying a caspase-independent cell-death pathway. Finally, Bax –/– animals bred to mice harboring various cerebellar mutations will determine whether BAX deletion can also rescue "diseased" granule cells in vivo. Assessing both the extent of neuroprotection and the recovery of cerebellar function may offer important insights into how modulation of the BCL-2 family may affect neurological disease.
| Acknowledgments |
|---|
Supported by National Institutes of Health Grants NS 24679 and AG12947 to E. Johnson, and by CA 49712 to S. Korsmeyer. K. Moulder is supported as a Lucille P. Markey predoctoral fellow, C. Knudson by a Pfizer Postdoctoral Fellowship, and M. Deshmukh by a Paralyzed Veterans of America Spinal Cord Research Foundation Grant 1786.
Submitted: 21 March 1997
Revised: 29 July 1997
Address all correspondence to Eugene M. Johnson, Jr., Washington University School of Medicine, Department of Molecular Biology and Pharmacology, 660 South Euclid Avenue, Box 8103, St. Louis, MO 63110. Tel.: (314) 362-3926. Fax: (314) 362-7058. E-mail: ejohnson{at}pharmdec.wustl.edu
| REFERENCES |
|---|
|
|
|---|
Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC & Tomaselli KJ. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors, J Biol Chem, 1996, 271, 16850–16855.
Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC & Tomaselli K. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis, J Neurosci, 1997, 17, 553–562.
Asahi M, Hoshimaru M, Uemura Y, Tokime T, Kojima M, Ohtsuka T, Matsuura N, Aoki T, Shibahara K & Kikuchi H. Expression of interleukin-1β converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery, J Cerebr Blood Flow Metab, 1997, 17, 11–18.[Medline]
Balazs R, Jorgensen OS & Hack N. N-Methyl-D-Aspartate promotes the survival of cerebellar granule cells in culture, Neuroscience, 1988, 27, 437–451.[Medline]
Binetruy B, Smeal T & Karin M. HaRas augments c-Jun activity and stimulates phosphorylation of its activation domain, Nature (Lond), 1991, 351, 122–127.[Medline]
Bos JL. A target for phosphoinositide 3-kinase: Akt/PKB, Trends Biochem Sci, 1995, 20, 441–442.[Medline]
Boudreau N, Sympson CJ, Werb Z & Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cell by extracellular matrix, Science (Wash DC), 1995, 267, 891–893.
Bozyczko CD, McKenna BW, Connors TJ & Neff NT. A rapid fluorometric assay to measure neuronal survival in vitro, J Neurosci Methods, 1993, 50, 205–216.[Medline]
Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T & Li P. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35, Science (Wash DC), 1995, 269, 1885–1888.
Burgoyne RD, Graham ME & Cambray DM. Neurotrophic effects of NMDA receptor activation on developing cerebellar granule cells, J Neurocytol, 1993, 22, 689–695.[Medline]
Caddy KW & Biscoe TJ. Structural and quantitative studies on the normal C3H and Lurcher mutant mouse, Philos Trans R Soc Lond B Biol Sci, 1979, 287, 167–201.
Cain K, Inayai-Hussain SH, Couet C & Cohen GM. A cleavage-site-directed inhibitor of interleukin-1β-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes, Biochem J, 1996, 314, 27–32.[Medline]
Chen YR, Meyer CF & Tan TH. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis, J Biol Chem, 1996, 271, 631–634.
Chinnaiyan AM, Orth K, O'Rourke K, Duan HJ, Poirier GG & Dixit VM. Molecular ordering of the cell death pathway—bcl-2 and bcl-x(L) function upstream of the ced-3-like apoptotic proteases, J Biol Chem, 1996, 271, 4573–4576.
Chittenden T, Flemmington S, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G & Lutz RJ. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions, EMBO (Eur Mol Biol Organ) J, 1995, 14, 5589–5596.[Medline]
Cidlowski JA. Glucocorticoids stimulate ribonucleic acid degradation in isolated rat thymic lymphocytes in vitro, Endocrinology, 1982, 111, 184–190.
Clarke PGH & Clarke S. Nineteenth-century research on naturally occurring cell death and related phenomenon, Anat Embryol, 1996, 193, 81–99.[Medline]
Creedon DJ, Johnson EM Jr & Lawrence JC. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival, J Biol Chem, 1996, 271, 20713–20718.
D'Mello SR, Galli C, Ciotti T & Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP, Proc Natl Acad Sci USA, 1993, 90, 10989–10993.
Deckwerth TL, Elliott JL, Knudson CM, Johnson EM Jr, Snider WD & Korsmeyer SJ. Bax is required for neuronal death after trophic factor deprivation and during development, Neuron, 1996, 17, 401–411.[Medline]
Deckwerth TL & Johnson EM Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor (NGF), J Cell Biol, 1993, 123, 1207–1222.
Deshmukh M, Vasilakos J, Deckwerth TL, Lampe PA, Shivers BD & Johnson EM Jr. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases, J Cell Biol, 1996, 135, 1341–1354.
Dessi F, Charriaut-Marlangue C, Khrestchatisky M & Ben-Ari Y. Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture, J Neurochem, 1993, 60, 1953–1955.[Medline]
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR & Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt, Science (Wash DC), 1997, 275, 661–667.
Estus, S. 1997. Optimization and validation of RT-PCR as a tool to analyze apoptotic gene expression. In NeuroMethods. J. Poirier, editor. Humana Press, Totowa, NJ. 67–84.
Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R & Johnson EM Jr. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis, J Cell Biol, 1994, 127, 1717–1727.
Ferrer I, Olive M, Ribera J & Planas AM. Naturally occurring (programmed) and radiation-induced apoptosis are associated with selective c-Jun expression in the developing rat brain, Eur J Neurosci, 1996, 8, 1286–1298.[Medline]
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR & Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase, Cell, 1995, 81, 727–736.[Medline]
Freeman RS, Estus S, Horigome K & Johnson EM Jr. Cell death genes in invertebrates and (maybe) vertebrates, Curr Opin Neurobiol, 1993, 3, 25–31.[Medline]
Freeman RS, Estus S & Johnson EM Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death, Neuron, 1994, 12, 343–355.[Medline]
Gajewski TF & Thompson CB. Apoptosis meets signal transduction: elimination of a BAD influence, Cell, 1996, 87, 589–592.[Medline]
Gallo V, Kingsbury A, Balazs R & Jorgensen OS. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture, J Neurosci, 1987, 7, 2203–2213.[Abstract]
Gavrieli Y, Sherman Y & Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, 1992, 119, 493–501.
Ghosh A, Ginty DD, Bading H & Greenberg ME. Calcium regulation of gene expression in neuronal cells, J Neurobiol, 1994, 25, 294–303.[Medline]
Gillardon F, Baurle J, Grusser-Cornehls U & Zimmermann M. DNA fragmentation and the activation of c-Jun in the cerebellum of mutant mice (weaver, Purkinje cell degeneration), Neuroreport, 1995, 6, 1766–1768.[Medline]
Glucksman A. Cell deaths in normal vertebrate ontogeny, Biol Rev Camb Philos Soc, 1951, 26, 59–86.
Greenlund LJ, Deckwerth TL & Johnson EJ. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death, Neuron, 1995a, 14, 303–315.[Medline]
Greenlund LJ, Korsmeyer SJ & Johnson EM Jr. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons, Neuron, 1995b, 15, 649–661.[Medline]
Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M & Rubin LL. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death, Neuron, 1995, 14, 927–939.[Medline]
Hay BA, Wolff T & Rubin GM. Expression of baculovirus P35 prevents cell death in Drosophila, Development (Camb), 1994, 120, 2121–2129.[Abstract]
Henkart PA. ICE family proteases: mediators of all apoptotic cell death, Immunity, 1996, 4, 195–201.[Medline]
Hibi M, Lin A, Smeal T, Minden A & Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain, Genes Dev, 1993, 7, 2135–2148.
Kingsbury AE, Gallo V, Woodhams PL & Balazs R. Survival, morphology and adhesion properties of cerebellar interneurones cultured in chemically defined and serum-supplemented medium, Dev Brain Res, 1985, 17, 17–25.
Knudson CM, Tung KSK, Tourtelotte WG, Brown GAJ & Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death, Science (Wash DC), 1995, 270, 96–99.
Korsmeyer SJ. Regulators of cell death, Trends Genet, 1996, 11, 101–105.[Medline]
Kuida K, Zheng TS, Na S, Kuan C-y, Yang D, Karasuyama H, Rakic P & Flavell R. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice, Nature (Lond), 1996, 384, 368–372.[Medline]
Lafon-Cazal M, Pietri S, Culcasi M & Bockaert J. NMDA-dependent superoxide production and neurotoxicity, Nature (Lond), 1993, 364, 535–537.[Medline]
Latinis KM & Koretzky GA. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells, Blood, 1996, 87, 871–875.
Lazebnik YA, Takahashi R, Moir R, Goldman R, Poirier G & Earnshaw WC. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution, Proc Natl Acad Sci USA, 1995, 92, 9042–9046.
Levi G, Aloisi F, Ciotti MT & Gallo V. Autographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures, Brain Res, 1984, 290, 77–86.[Medline]
Linnik MD. Role of apoptosis in acute neurodegenerative disorders, Restor Neurol, 1996, 9, 219–225.
Makman MH, Dvorkin B & White A. Alterations in protein and nucleic acid metabolism of thymocytes produced by adrenal steroids in vitro, J Biol Chem, 1966, 241, 1646–1648.
Martinou I, Fernandez PA, Missotten M, White E, Allet B, Sadoul R & Martinou J-C. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation, J Cell Biol, 1995, 128, 201–208.
McCarthy NJ, Whyte MKB, Gilbert CS & Evan GI. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak, J Cell Biol, 1997, 136, 215–227.
Miller TM & Johnson EM Jr. Metabolic and genetic analysis of apoptosis in rat cerebellar granule cells, J Neurosci, 1996, 16, 7487–7495.
Miller TM, Tansey MG, Johnson EM Jr & Creedon DJ. Inhibition of phosphatidylinositol 3-kinase blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells, J Biol Chem, 1997, 272, 9847–9853.
Motoyama N, Wang FP, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S & Loh DY. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice, Science (Wash DC), 1995, 267, 1506–1510.
Munck A. Metabolic site and time course of cortisol action on glucose uptake, lactic acid output, and glucose 6–phosphate levels of rat thymus cells in vitro, J Biol Chem, 1968, 243, 1039–1042.
Nardi N, Avidan G, Daily D, Zilkha-Falb R & Barzilai A. Biochemical and temporal analysis of events associated with apoptosis induced by lowering the extracellular potassium concentration in mouse cerebellar granule neurons, J Neurochem, 1997, 68, 750–759.[Medline]
Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB & Wang KKW. Non-erythroid
-spectrin breakdown by calpain and interleukin 1β-converting enzyme-like protease(s) in apoptotic cells:contributory roles of both protease families in neuronal apoptosis, Biochem J, 1996, 319, 683–690.[Medline]
Oltvai ZN, Milliman CL & Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, 1993, 74, 609–619.[Medline]
Park DS, Stefanis L, Yan CYI, Farinelli SE & Greene LA. Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1β-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells, J Biol Chem, 1996, 271, 21898–21905.
Rabizadeh S, LaCount DJ, Friesen PD & Bredesen DE. Expression of the baculovirus p35 gene inhibits mammalian neural cell death, J Neurochem, 1993, 61, 2318–2321.[Medline]
Rao L, Perez D & White E. Lamin proteolysis facilitates nuclear events during apoptosis, J Cell Biol, 1996, 135, 1441–1455.
Schramm M, Eimerl S & Costa E. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-D-aspartate, Proc Natl Acad Sci USA, 1990, 87, 1193–1197.
Schulz JB, Weller M & Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons; a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species, J Neurosci, 1996, 16, 4696–4706.
Schwartz LM & Milligan CE. Cold thoughts of death—the role of ICE proteases in neuronal cell death, Trends Neurosci, 1996, 19, 555–562.[Medline]
Short JM, Fernandez JM, Sorge JA & Huse WD. Lambda ZAP: a bacteriophage Lambda expression vector with in vivo excision properties, Nucleic Acids Res, 1988, 16, 7583–7600.
Smeal T, Binetruy B, Mercola D, Birrer M & Karin M. Oncogenic and transcriptional cooperation with HaRas requires phosphorylation of c-Jun on serines 63 and 73, Nature (Lond), 1991, 354, 494–496.[Medline]
Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR & Karin M. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73, Mol Cell Biol, 1992, 12, 3507–3513.
Srinivasan A, Foster LM, Testa MP, Ord T, Keane RW, Bredesen DE & Kayalar C. Bcl-2 expression in neural cells blocks activation of Ice/ced-3 family proteases during apoptosis, J Neurosci, 1996, 16, 5654–5660.
Stefanis L, Park DS, Yan CYI, Farinelli SE, Troy CM, Shelanski ML & Greene LA. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support—dissociation from apoptosis, J Biol Chem, 1996, 271, 30663–30671.
Sugimoto A, Friesen PD & Rothman JH. Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. , EMBO (Eur Mol Biol Organ) J, 1994, 13, 2023–2028.[Medline]
Thangnipon W, Kingsbury A, Webb M & Balazs R. Observations on rat cerebellar cells in vitro: influence of substratum, potassium concentration and relationship between neurones and astrocytes, Dev Brain Res, 1983, 11, 177–189.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM et al.. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis, Nature (Lond), 1996, 380, 75–79.[Medline]
Virdee K & Tolkovsky A. Inhibition of p42 and p44 mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurones, J Neurochem, 1996, 67, 1801–1805.[Medline]
Wang H-G, Rapp UR & Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria, Cell, 1996, 87, 629–638.[Medline]
Wetts R & Herrup K. Direct correlation between Purkinje and granule cell number in the cerebella of lurcher chimeras and wild-type mice, Dev Brain Res, 1983, 10, 41–47.
White E. Life, death, and the pursuit of apoptosis, Genes Dev, 1996, 10, 1–15.
Williams RW & Herrup K. The control of neuron number, Annu Rev Neurosci, 1988, 11, 423–453.[Medline]
Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA & Budd RC. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells, Eur J Immunol, 1996, 26, 989–994.[Medline]
Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN & Iverson LL. The anti-convulsant MK-801 is a potent NMDA antagonist, Proc Natl Acad Sci USA, 1986, 83, 7104–7108.
Xia Z, Dickens M, Raingeaud J, Davis RJ & Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science (Wash DC), 1995, 270, 1326–1331.
Xiang JL, Chao DT & Korsmeyer SJ. Bax-induced cell death may not require interleukin 1β–converting enzyme-like proteases, Proc Natl Acad Sci USA, 1996, 93, 14559–14563.
Xue D & Horvitz HR. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein, Nature (Lond), 1995, 377, 248–251.[Medline]
Yin XM, Oltvai Z & Korsmeyer S. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature (Lond), 1994, 369, 321–323.[Medline]
Zha J, Harada H, Yang E, Jockel J & Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-XL, Cell, 1996, 87, 619–628.[Medline]
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|